Litcius/Paper detail

Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration

Ning Ji, Hui Li, Yixuan Zhang, Yuelin Li, Yuelin Li, Peiyu Wang, Xin Chen, Yinan Liu, Jing‐Quan Wang, Yuqi Yang, Zhe‐Sheng Chen, Yueguo Li, Yueguo Li, Ran Wang, Kong De, Yueguo Li, Ran Wang, Kong De

2024Drug Resistance Updates28 citationsDOI

Topics & Concepts

EffluxATP-binding cassette transporterLansoprazoleMultiple drug resistancePharmacologyAbcg2Drug resistanceDrugTransporterChemotherapeutic drugsCancerMedicineCancer researchChemistryBiologyMicrobiologyInternal medicineBiochemistryGeneOmeprazoleDrug Transport and Resistance MechanismsNanoparticle-Based Drug DeliveryCancer therapeutics and mechanisms
Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration | Litcius